Newsroom | 5311 results

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management will participate in a fireside chat presentation on Wednesday, June 3, 2026 at 3:10 pm ET. The presentation will be webcast and can be accessed here or on Varex’s website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray...

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the European Radiosurgery Center Munich (ERCM) has treated more than 1,000 patients with the ZAP-X® Gyroscopic Radiosurgery® platform. The milestone reflects ERCM’s continued leadership in stereotactic radiosurgery (SRS), a completely non-invasive and painless procedure used to treat many primary and metastatic brain tumors, as well as select disorders of...

LOS ANGELES--(BUSINESS WIRE)--Pearl today announced Pearl RCM, a revenue cycle management platform that embeds insurance intelligence throughout the dental workflow....

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer & RSNA sign 10-year deal to expand global access, visibility, & impact of leading radiology research journals & AI-focused titles....

BURLINGTON, Mass. & BELOIT, Wis.--(BUSINESS WIRE)--Partnership combines NorthStar’s commercial-scale radioisotope production capabilities with QSA Global’s expertise in management of Radium-226...

MADISON, Wis.--(BUSINESS WIRE)--Archeus Technologies, a clinical-stage company advancing a portfolio of differentiated small-molecule radiopharmaceutical therapies (RPTs) to address some of the most difficult-to-treat cancers, today announced that it has dosed the first patient in a Phase 1 clinical trial of ARC-706, and companion diagnostic ARC-166, in patients with metastatic cancer receiving immune checkpoint inhibition (ICI) therapies. Archeus is developing ARC-706 for combination use with...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched GoodRx Companion, a new $14.99-per-month subscription that brings together free and low-cost generic medications, affordable online care visits, and savings on additional healthcare services in one simple program. Built for a healthcare environment where consumers are increasingly shouldering more out-of-pocket costs, even when they have insurance, Companion tu...

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announces that it is expected to be added to the Russell Microcap® Index according to the list of additions posted online May 22, 2026. The addition of QT Imaging to this Index will be finalized at the conclusion of the 2026 Russell indexes reconstitution and, i...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies receives notice of allowance for Mexican patent on methods of predicting the likelihood of lung cancer using flow cytometry....

BOLOGNA, Italy--(BUSINESS WIRE)--Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare and specialty care where there is significant unmet patient need, presented positive results from the OLINGUITO Phase 3 clinical trial (NCT05785611i EudraCT 2022-501354-10-01ii) at EULAR 2026. In OLINGUITO filgotinib, an oral, once-daily JAK1 preferential inhibitor under investigation for the treatment of adult patients with active axial spondyloarthritis (axSpA), demonstrated su...